G
genhealth.ai
Introducting DOOG-E: A GPT built on medical events
About genhealth.ai
GenHealth.ai is a U.S. health-technology company spun out of interoperability firm 1upHealth and led by CEO Ricky Sahu that builds AI agents for the medical back office—automating intake, eligibility checks, prior authorization, billing, denials and appeals so practices and suppliers spend less staff time chasing revenue already earned. Agents work alongside existing teams and systems of record; the company cites customer outcomes such as higher collected revenue and large cuts in administrative cost, aiming at the roughly $1 trillion U.S. healthcare administration burden with approaches designed to be accurate and cost-effective without heavy image-based computer-vision overhead. Founded in 2023, GenHealth in September 2026 raised a $16.5 million Series A led by Flare Capital Partners, with Craft Ventures, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health Investors and ARTIS participating, bringing total funding to about $30 million to onboard customers, deepen workflows and improve models that learn customer processes passively. Sources: MedCity News 11 Sep 2026; Health Technology Net; FinSMEs.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2026 | $17M | $66M | Eniac Ventures · Epsilon Health Investors · Obvious Ventures · Craft Ventures | ↗ |
| SEEDEquity / VC | Apr 2024 | $0 | — | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for genhealth.ai is 88K monthly website visits, up 300% over the last three months. genhealth.ai's team grew 40% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Flare Capital Partners
Eniac Ventures
Epsilon Health Investors
Obvious Ventures
Craft Ventures
InHealth Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about genhealth.ai on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See genhealth.ai’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







